Biomea Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes Experts

Biomea Fusion, Inc. announced the formation of Biomea Fusion’s Global Scientific Advisory Board (SAB) with internationally renowned experts in beta cell science and diabetes therapeutics. The SAB will work closely with Biomea’s leadership team as they unlock menin science and beta cell biology to design disease modifying agents that address a root cause of diabetes – beta cell dysfunction.